MENU
ARMP
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Armata Pharmaceuticals (ARMP) Earnings Date & Reports

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ARMP is expected to report earnings to fall 44.59% to -40 cents per share on March 19

Armata Pharmaceuticals ARMP Stock Earnings Reports
Q4'25
Est.
$-0.41
Q3'25
Missed
by $0.24
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.06
The last earnings report on November 12 showed earnings per share of -74 cents, missing the estimate of -50 cents. With 87.86K shares outstanding, the current market capitalization sits at 231.15M.
View a ticker or compare two or three
ARMP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARMP showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of novel bacteriophage-based therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5005 McConnell Avenue
Phone
+1 310 665-2928
Employees
66
Web
https://www.armatapharma.com